|
|
|
CONFERENCE PROGRAMMEDay 1 - 6th September 2010 |
||
|
||||
|
||||
|
||||
|
Sir Greg Winter CBE FRS - MRC Laboratory of Molecular Biology, UK |
||||
|
||||
|
Richard Lerner - President, The Scripps Research Institute, USA |
||||
|
||||
|
John McCafferty - University of Cambridge, UK |
|
|||
|
||||
|
Carl Borrebaeck - Deputy Vice Chancellor, Program Director CREATE Health Cancer Center, Sweden |
|
|||
|
||||
|
Jim Huston - Boston Biomedical Research Institute, USA |
|
|||
|
||||
|
Richard Begent - Head, Cancer Research UK Targeting and Imaging Group, UCL Cancer Institute, UK |
|
|||
|
||||
|
Andreas Plückthun - Professor of Biochemistry, University of Zurich, Switzerland |
|
|||
|
||||
|
Bob Ladner - Chief Technology Officer and Senior Vice President, Dyax Corp, USA |
||||
|
||||
|
Jane Osbourn - Site Leader and VP Research, MedImmune, Cambridge, UK |
|
|||
|
||||
|
Diane Wilcock - Director, Intellectual Property, XOMA (US) LLC, USA |
|
|||
|
||||
|
Panel Discussion: Twenty Years of Phage Display: the Highs and Lows |
||||
|
||||
|
Special Guest Lecture: The HUMIRA Story |
|
|||
|
||||
|
Sponsors:
|
||||